Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
Due to its low solubility, carbamazepine (CBZ) exhibits slow and incomplete release in the gastrointestinal tract and, hence, variable pharmacokinetics and pharmacodynamic effect. Lots of methods have been devised to improve its solubility, the large number of proposed solutions being a sign that th...
Saved in:
Main Authors: | Adina Magdalena Musuc (Author), Valentina Anuta (Author), Irina Atkinson (Author), Iulian Sarbu (Author), Vlad Tudor Popa (Author), Cornel Munteanu (Author), Constantin Mircioiu (Author), Emma Adriana Ozon (Author), George Mihai Nitulescu (Author), Mirela Adriana Mitu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex
by: Adina Magdalena Musuc, et al.
Published: (2020) -
Chewable Versus Regular Carbamazepine
by: J Gordon Millichap
Published: (1992) -
Formulation and development of paediatric orally disintegrating carbamazepine tablets
by: R Canadell-Heredia, et al.
Published: (2022) -
Process induced degradation of carbamazepine during hot melt extrusion
by: Sarbamangala Bose, et al.
Published: (2023) -
Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets
by: Emma Adriana Ozon, et al.
Published: (2022)